fashion -WSS

fashion

author：hotspot 2025-10-01 17:21:43 - browse：657

What happens when an approved drug doesn’t work? Why don’t patients want gene therapy? And is MASH still a big deal?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Bioethicist Holly Fernandez Lynch joins us to discuss the case of Amylyx Pharmaceuticals’ treatment for ALS and what its failure means for drug development. We also discuss the latest news in the life sciences, including a tepid reception for gene therapies, the future of CAR-T cancer treatment, and the first approved medicine for a prevalent liver disease.

For more on what we cover, here’s more on Amylyx; here’s the story on hemophilia gene therapy; here’s the news on Madrigal Pharmaceuticals’ drug for MASH; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Virginia high school admissions case could be legal follow
Next article： Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

focus

WSS

GSK to buy asthma

Caregivers of transplant patients call for more support, training

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

Readout LOUD podcast: live from JPM 2024

Will the IRA bring competition to the biologics market?

Doulas covered by Medicaid under New York's new plan

focus

fashion

Wikipedia

After affirmative action ruling, medical educators look to 'holistic review'

Heart disease and mental health: A look at cardiac psychology

Medical leaders decry Supreme Court decision on affirmative action

What to make of Biden’s latest efforts on cancer research

DIEP, the 'gold standard' of breast reconstruction, is under threat

Walmart eyes Medicare Advantage provider ChenMed

Tori Bowie and the unacceptable rates of Black maternal death

New menopause drug shows promise in relief for hot flashes

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

FDA approves updated Covid vaccines

Wikipedia

Food makers tried to stack nutrition panel with preferred experts

How to make the FDA’s new prescription one

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

The SUPPORT Act is critical to fighting the opioid crisis

focus

entertainment

focus

explore